This session highlights the most clinically relevant abstracts within the Breast Cancer track of the 2023 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.

Adaptive radiotherapy is emerging as a treatment approach for patients with improvements in technology that allow real-time planning and consequent treatment delivery. Different imaging modalities are used, such as MR and CBCT, for image guidance.

Online adaptive radiotherapy (ART) is a current and emerging technology and approach that leverages CT and MR images obtained on the treatment delivery platform to personalized daily RT fractions to account for organ and tumor motion, deformation, and positioning with the potential of improving o

Sinonasal and salivary malignancies are less common head and neck tumors but are still frequently seen by radiation oncologists and pose complex clinical decision making challenges due to the proximity to the facial nerve, optic structures, brain, and oral cavity.

Significant data reveal that cancer patients use complementary/integrative therapies and may not share this with their physician team.

This activity presents a multi-part session starting with two primarily didactic sessions on mentorship for the early career radiation oncologist and practice building.

Recent publications have established SBRT as the standard of care in painful spine metastases. As a result, spine SBRT is being increasingly utilized in both academic and community practices, rendering this educational activity timely.

The Cancer Breakthroughs activity brings together several medical societies in a collaborative effort to provide a summary of this year’s groundbreaking cancer studies.

This activity will begin with a review of the data for hypofractionation of regional nodal irradiation (RNI). That review will cover patients with intact breasts, post-mastectomy without reconstruction and post-mastectomy with reconstruction.

Brachytherapy is a critical component to the optimal management of locally advanced cervical cancer. However, due to many factors, its use was declining in the 2010s and when brachytherapy is omitted, patient outcomes are worse.